BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36107242)

  • 1. Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.
    Zhai C; Zhang N; Wang J; Cao M; Luan J; Liu H; Zhang Q; Zhu Y; Xue Y; Li S
    Lung; 2022 Oct; 200(5):619-631. PubMed ID: 36107242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
    Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel alleviates monocrotaline-induced pulmonary arterial hypertension via inhibition of FoxO1-mediated autophagy.
    Feng W; Wang J; Yan X; Zhai C; Shi W; Wang Q; Zhang Q; Li M
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):605-613. PubMed ID: 30683943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP.
    Wang Q; Shi W; Zhang Q; Feng W; Wang J; Zhai C; Yan X; Li M
    Life Sci; 2020 Feb; 242():117159. PubMed ID: 31837334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
    Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
    Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ubiquitin proteasome function prevents monocrotaline-induced pulmonary arterial remodeling.
    Zhu Y; Wu Y; Shi W; Wang J; Yan X; Wang Q; Liu Y; Yang L; Gao L; Li M
    Life Sci; 2017 Mar; 173():36-42. PubMed ID: 28212825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.
    Bourgeois A; Lambert C; Habbout K; Ranchoux B; Paquet-Marceau S; Trinh I; Breuils-Bonnet S; Paradis R; Nadeau V; Paulin R; Provencher S; Bonnet S; Boucherat O
    J Mol Med (Berl); 2018 Feb; 96(2):223-235. PubMed ID: 29290032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a.
    Li F; Wang D; Wang H; Chen L; Sun X; Wan Y
    Respir Res; 2021 Aug; 22(1):239. PubMed ID: 34465322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
    Beik A; Najafipour H; Joukar S; Rajabi S; Iranpour M; Kordestani Z
    Clin Exp Hypertens; 2021 Apr; 43(3):270-280. PubMed ID: 33322932
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats.
    Tang C; Luo Y; Li S; Huang B; Xu S; Li L
    Biomed Pharmacother; 2021 Jan; 133():111081. PubMed ID: 33378977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydromyricetin prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Li Q; Wang J; Zhu X; Zeng Z; Wu X; Xu Y; Xie J; Yu J
    Biomed Pharmacother; 2017 Dec; 96():825-833. PubMed ID: 29078260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
    Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y
    Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
    Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
    Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    Cheng Y; Yu M; Xu J; He M; Wang H; Kong H; Xie W
    BMC Pulm Med; 2018 Aug; 18(1):130. PubMed ID: 30086741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
    Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
    BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
    Gao H; Cheng Y; Zong L; Huang L; Qiao C; Li W; Gong B; Hu J; Liu H; Wang X; Zhao C
    Clin Exp Hypertens; 2017; 39(1):34-41. PubMed ID: 28055284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of free and nanoemulsified β-caryophyllene on monocrotaline-induced pulmonary arterial hypertension.
    Carraro CC; Turck P; Bahr A; Donatti L; Corssac G; Lacerda D; da Rosa Araujo AS; de Castro AL; Koester L; Belló-Klein A
    Biochim Biophys Acta Mol Cell Res; 2024 Apr; 1871(4):119704. PubMed ID: 38462075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways.
    Yu M; Wu X; Wang J; He M; Han H; Hu S; Xu J; Yang M; Tan Q; Wang Y; Wang H; Xie W; Kong H
    Int J Med Sci; 2022; 19(4):681-694. PubMed ID: 35582418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.